Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

FAK alternative splice mRNA variants expression pattern in colorectal cancer.

Devaud C, Tilkin-Mariamé AF, Vignolle-Vidoni A, Souleres P, Denadai-Souza A, Rolland C, Duthoit C, Blanpied C, Chabot S, Bouillé P, Lluel P, Vergnolle N, Racaud-Sultan C, Ferrand A.

Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32120. [Epub ahead of print]

PMID:
30628725
2.

Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction.

Seefeld MA, Lin H, Holenz J, Downie D, Donovan B, Fu T, Pasikanti K, Zhen W, Cato M, Chaudhary KW, Brady P, Bakshi T, Morrow D, Rajagopal S, Samanta SK, Madhyastha N, Kuppusamy BM, Dougherty RW, Bhamidipati R, Mohd Z, Higgins GA, Chapman M, Rouget C, Lluel P, Matsuoka Y.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3793-3797. doi: 10.1016/j.bmcl.2018.09.036. Epub 2018 Sep 29.

PMID:
30327146
3.

Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism.

Sébert M, Denadai-Souza A, Quaranta M, Racaud-Sultan C, Chabot S, Lluel P, Monjotin N, Alric L, Portier G, Kirzin S, Bonnet D, Ferrand A, Vergnolle N.

Br J Pharmacol. 2018 Sep;175(18):3656-3668. doi: 10.1111/bph.14430. Epub 2018 Aug 7.

4.

OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor.

Pohl O, Chollet A, Kim SH, Riaposova L, Spézia F, Gervais F, Guillaume P, Lluel P, Méen M, Lemaux F, Terzidou V, Bennett PR, Gotteland JP.

J Pharmacol Exp Ther. 2018 Aug;366(2):349-364. doi: 10.1124/jpet.118.247668. Epub 2018 May 18.

PMID:
29777040
5.

Mobilization of CD4+ T lymphocytes in inflamed mucosa reduces pain in colitis mice: toward a vaccinal strategy to alleviate inflammatory visceral pain.

Basso L, Boué J, Augé C, Deraison C, Blanpied C, Cenac N, Lluel P, Vergnolle N, Dietrich G.

Pain. 2018 Feb;159(2):331-341. doi: 10.1097/j.pain.0000000000001103.

PMID:
29140925
6.

Ketanserin and Naftopidil Enhance the Potentiating Effect of Alpha-Methyl-Serotonin on the Neurally-Induced Contraction of Human Isolated Urinary Bladder Muscle Strips.

Hattori T, Lluel P, Rouget C, Rekik M, Yoshiyama M.

Int Neurourol J. 2017 Mar 24;21(1):20-28. doi: 10.5213/inj.1732758.379.

7.

Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs.

Palea S, Guilloteau V, Rekik M, Lovati E, Guerard M, Guardia MA, Lluel P, Pietra C, Yoshiyama M.

Front Pharmacol. 2016 Aug 4;7:234. doi: 10.3389/fphar.2016.00234. eCollection 2016.

8.

Comparison of the effects of β3 -adrenoceptor agonism on urinary bladder function in conscious, anesthetized, and spinal cord injured rats.

Beauval JB, Guilloteau V, Cappellini M, Westfall TD, Rischmann P, Palea S, Gamé X, Lluel P.

Neurourol Urodyn. 2015 Aug;34(6):578-85. doi: 10.1002/nau.22629. Epub 2014 Jun 17.

PMID:
24938622
9.

Modulation of nerve-evoked contractions by β3-adrenoceptor agonism in human and rat isolated urinary bladder.

Rouget C, Rekik M, Camparo P, Botto H, Rischmann P, Lluel P, Palea S, Westfall TD.

Pharmacol Res. 2014 Feb;80:14-20. doi: 10.1016/j.phrs.2013.12.006. Epub 2013 Dec 28.

PMID:
24378642
10.

ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.

Kalinichev M, Palea S, Haddouk H, Royer-Urios I, Guilloteau V, Lluel P, Schneider M, Saporito M, Poli S.

Br J Pharmacol. 2014 Feb;171(4):995-1006. doi: 10.1111/bph.12517.

11.

Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder.

Augé C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM.

Eur J Pharmacol. 2013 May 5;707(1-3):32-40. doi: 10.1016/j.ejphar.2013.03.008. Epub 2013 Mar 26.

PMID:
23541724
12.

Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats.

Palea S, Maiga A, Guilloteau V, Rekik M, Guérard M, Rouget C, Rischmann P, Botto H, Camparo P, Lluel P, Gilles N.

Br J Pharmacol. 2013 Feb;168(3):618-31. doi: 10.1111/j.1476-5381.2012.02231.x.

13.

Fenoterol functionally activates the β₃-adrenoceptor in human urinary bladder, comparison with rat and mouse: implications for drug discovery.

Palea S, Rekik M, Rouget C, Camparo P, Botto H, Rischmann P, Lluel P, Westfall TD.

Eur J Pharmacol. 2012 Sep 5;690(1-3):202-6. doi: 10.1016/j.ejphar.2012.06.036. Epub 2012 Jul 1.

PMID:
22760074
14.

Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.

Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C.

BJU Int. 2012 Jul;110(2 Pt 2):E132-42. doi: 10.1111/j.1464-410X.2012.11240.x.

15.

G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors.

Maïga A, Mourier G, Quinton L, Rouget C, Gales C, Denis C, Lluel P, Sénard JM, Palea S, Servent D, Gilles N.

Toxicon. 2012 Mar 15;59(4):487-96. doi: 10.1016/j.toxicon.2011.03.009. Epub 2011 Mar 22.

PMID:
21419153
16.

Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.

Pérez-Martínez FC, Vela-Navarrete R, Virseda J, Ocaña AV, Lluel P, Rekik M, Bienaymé H, Ferté J, Attali P, Palea S.

Urol Int. 2011;86(2):210-9. doi: 10.1159/000321226. Epub 2010 Nov 13.

PMID:
21071917
17.

5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT(7) and 5-HT(2C) receptors.

Rekik M, Lluel P, Palea S.

Eur J Pharmacol. 2011 Jan 10;650(1):403-10. doi: 10.1016/j.ejphar.2010.10.027. Epub 2010 Oct 20.

PMID:
20969855
18.

Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.

Quinton L, Girard E, Maiga A, Rekik M, Lluel P, Masuyer G, Larregola M, Marquer C, Ciolek J, Magnin T, Wagner R, Molgó J, Thai R, Fruchart-Gaillard C, Mourier G, Chamot-Rooke J, Ménez A, Palea S, Servent D, Gilles N.

Br J Pharmacol. 2010 Jan 1;159(2):316-25. doi: 10.1111/j.1476-5381.2009.00532.x. Epub 2009 Dec 15.

19.

Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex.

Deba A, Palea S, Rouget C, Westfall TD, Lluel P.

Eur J Pharmacol. 2009 Sep 15;618(1-3):76-83. doi: 10.1016/j.ejphar.2009.07.012. Epub 2009 Jul 18.

PMID:
19619525
20.

Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.

Palea S, Chang DF, Rekik M, Regnier A, Lluel P.

J Cataract Refract Surg. 2008 Mar;34(3):489-96. doi: 10.1016/j.jcrs.2007.10.045.

PMID:
18299077
21.

Involvement of 5-hydroxytryptamine (HT)7 receptors in the 5-HT excitatory effects on the rat urinary bladder.

Palea S, Lluel P, Barras M, Duquenne C, Galzin AM, Arbilla S.

BJU Int. 2004 Nov;94(7):1125-31.

22.

New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.

Trellu M, Filali-Ansary A, Françon D, Adam R, Lluel P, Dubruc C, Thénot JP.

Fundam Clin Pharmacol. 2004 Aug;18(4):493-501.

PMID:
15312157
23.

Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders.

Lluel P, Palea S, Ribière P, Barras M, Teillet L, Corman B.

Fundam Clin Pharmacol. 2003 Oct;17(5):633-41.

PMID:
14703725
24.

Age-related changes in urethrovesical coordination in male rats: relationship with bladder instability?

Lluel P, Deplanne V, Heudes D, Bruneval P, Palea S.

Am J Physiol Regul Integr Comp Physiol. 2003 May;284(5):R1287-95. Epub 2002 Dec 27.

25.
26.

Functional and morphological modifications of the urinary bladder in aging female rats.

Lluel P, Palea S, Barras M, Grandadam F, Heudes D, Bruneval P, Corman B, Martin DJ.

Am J Physiol Regul Integr Comp Physiol. 2000 Apr;278(4):R964-72.

27.

Pharmacological and urodynamic changes in rat urinary bladder function after multiple pregnancies.

Grandadam F, Lluel P, Palea S, Martin DJ.

BJU Int. 1999 Nov;84(7):861-6.

PMID:
10532987
28.

Experimental bladder instability following bladder outlet obstruction in the female rat.

Lluel P, Duquenne C, Martin D.

J Urol. 1998 Dec;160(6 Pt 1):2253-7.

PMID:
9817379
29.

Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations.

Martin DJ, Lluel P, Pouyet T, Rauch-Desanti C, Angel I.

Life Sci. 1998;63(3):169-76.

PMID:
9698046
30.

Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.

Martin DJ, Lluel P, Guillot E, Coste A, Jammes D, Angel I.

J Pharmacol Exp Ther. 1997 Jul;282(1):228-35.

PMID:
9223558
31.

Vasopressin V2 receptor mRNA expression and cAMP accumulation in aging rat kidney.

Klingler C, Preisser L, Barrault MB, Lluel P, Horgen L, Teillet L, Ancellin N, Corman B.

Am J Physiol. 1997 Jun;272(6 Pt 2):R1775-82.

PMID:
9227590

Supplemental Content

Support Center